Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CITED2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
LOC400541 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CEMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEBL-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TFRC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MGC10814 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
LYZL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOXP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYT5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYCN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPATA6L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100287576 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMD5-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RGL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on